iPSC Cell Bank Biosafety & Qualification

iPSC Cell Bank Testing and GMP Characterization

Identity, genetic-stability, microbial, adventitious-agent, and cell-bank qualification support for iPSC and related cell-substrate programs.

Request a Quote Contact a Scientific Project Manager

Modality > Cell & Gene Therapy (CGT) > iPSC Cell Bank Testing (GMP)

Program Overview

iPSC and related cell-substrate programs require controlled qualification packages built around identity, genetic stability, microbial safety, adventitious-agent control, and release-ready documentation. HyQure supports iPSC or MSC-related programs through cell line or cell-bank characterization, in vitro or in vivo virus-testing pathways where relevant, retrovirus-related methods, and quality-controlled reporting for MCB, WCB, EOPC, and related matrices.

Why HyQure - Advantages

Cell-substrate identity and stability support

Identity, genetic-stability, and cell-bank qualification remain central, while non-routine stemness-marker or differentiation requests are handled through separate technical scoping.
Adventitious-agent and virus-testing coverage

in-vitro virus testing, in-vivo virus testing where required, retrovirus-related methods, and microbial pathways are central to the supported scope.
Microbial and release-ready workflows

Mycoplasma, sterility, endotoxin support, and related release-facing documentation strengthen release-aware workflows and sponsor-facing quality documentation.
Shipment and customs readiness

Risk assessment, donor or sample information requirements, customs coordination, and cold-chain shipment support are relevant to cell-line and cell-bank programs.

Comprehensive iPSC / Cell-Substrate Testing Panels

Cell bank qualification

MCB, WCB, EOPC, and related bank-qualification strategies aligned to program stage and target market.
Identity and genetic stability

Identity confirmation and genetic-stability pathways presented in line with HyQure's cell line and molecular testing scope.
Adventitious-agent and retrovirus-related testing

In vitro or in vivo virus testing, reverse-transcriptase-related methods, and other biosafety pathways for cell substrates.
Microbial safety and supporting QC

Mycoplasma, sterility, endotoxin support, and sponsor-facing quality documentation for release-aware workflows.

Sample Types and Deliverables

Sample types

Cryopreserved banks, live cultures, process intermediates, and related lysate or supernatant materials confirmed during study scoping.

Scoping inputs

Species, donor-origin information where required, customs documents, and shipment conditions should be defined before sample dispatch.

Key deliverables

Qualification reports, microbial and virus-test summaries, release-support documentation, and method-specific outputs based on the agreed testing package.

Program alignment

Non-routine characterization requests should be confirmed through technical scoping before they are presented as part of the formal testing package.